Season 25 Episode 33
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
Published on 1 month, 2 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate